Identification and functional characterization of human glycerol-3-phosphate acyltransferase 1 gene promoters

Biochemical and Biophysical Research Communications

Volumn 423, Issue 1, 2012, Pages 128-133

  Harada, Nagakatsu ^a   Fujimoto, Erika ^a   Okuyama, Maiko ^a   Sakaue, Hiroshi ^a   Nakaya, Yutaka ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Glycerol 3 phosphate acyltransferase 1; Human; Liver enriched transcription factors; Promoter; SREBP1

Indexed keywords

1 ACYLGLYCEROPHOSPHATE ACYLTRANSFERASE; CCAAT ENHANCER BINDING PROTEIN ALPHA; CCAAT ENHANCER BINDING PROTEIN BETA; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 1BETA; HEPATOCYTE NUCLEAR FACTOR 3ALPHA; HEPATOCYTE NUCLEAR FACTOR 3BETA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C;

ANIMAL CELL; ARTICLE; CELL STRAIN HEPG2; CONTROLLED STUDY; EXON; GENETIC ORGANIZATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; HELA CELL; HUMAN; HUMAN CELL; INTRON; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION INITIATION SITE;

ANIMALS; BINDING SITES; CCAAT-ENHANCER-BINDING PROTEINS; EXONS; GLYCEROL-3-PHOSPHATE O-ACYLTRANSFERASE; HELA CELLS; HEP G2 CELLS; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; INTRONS; LIVER; MICE; NIH 3T3 CELLS; PROMOTER REGIONS, GENETIC; RESPONSE ELEMENTS; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION, GENETIC;

MAMMALIA;

EID: 84862699879     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2012.05.094     Document Type: Article

References (23)

1. Coleman R.A., Mashek D.G. Mammalian triacylglycerol metabolism: synthesis, lipolysis, and signaling. Chem. Rev. 2011, 111:6359-6386.
2. Dircks L.K., Sul H.S. Mammalian mitochondrial glycerol-3-phosphate acyltransferase. Biochim. Biophys. Acta 1997, 1348:17-26.
3. Lindén D., William-Olsson L., Ahnmark A., et al. Liver-directed overexpression of mitochondrial glycerol-3-phosphate acyltransferase results in hepatic steatosis, increased triacylglycerol secretion and reduced fatty acid oxidation. FASEB J. 2006, 20:434-443.
4. Lindén D., William-Olsson L., Rhedin M., et al. Overexpression of mitochondrial GPAT in rat hepatocytes leads to decreased fatty acid oxidation and increased glycerolipid biosynthesis. J. Lipid Res. 2004, 45:1279-1288.
5. Jerkins A.A., Liu W.R., Lee S., et al. Characterization of the murine mitochondrial glycerol-3-phosphate acyltransferase promoter. J. Biol. Chem. 1995, 270:1416-1421.
6. Yoshida M., Harada N., Yamamoto H., et al. Identification of cis-acting promoter sequences required for expression of the glycerol-3-phosphate acyltransferase 1 gene in mice. Biochim. Biophys. Acta 2009, 1791:39-52.
7. Aneja K.K., Guha P., Shilpi R.Y., et al. The presence of distal and proximal promoters for rat mitochondrial glycerol-3-phosphate acyltransferase. Arch. Biochem. Biophys. 2008, 470:35-43.
8. Ericsson J., Jackson S.M., Kim J.B., et al. Identification of glycerol-3-phosphate acyltransferase as an adipocyte determination and differentiation factor 1- and sterol regulatory element-binding protein-responsive gene. J. Biol. Chem. 1997, 272:7298-7305.
9. Shin D.H., Paulauskis J.D., Moustaid N., et al. Transcriptional regulation of p90 with sequence homology to Escherichia coli glycerol-3-phosphate acyltransferase. J. Biol. Chem. 1991, 266:23834-23839.
10. Hughes D.E., Stolz D.B., Yu S., et al. Elevated hepatocyte levels of the Forkhead box A2 (HNF-3beta) transcription factor cause postnatal steatosis and mitochondrial damage. Hepatology 2003, 37:1414-1424.
11. Moya M., Benet M., Guzmán C., et al. Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic fatty liver. PLoS One 2012, 7:e30014.
12. Mori T., Sakaue H., Iguchi H., et al. Role of Krüppel-like factor 15 (KLF15) in transcriptional regulation of adipogenesis. J. Biol. Chem. 2005, 280:12867-12875.
13. Harada N., Yonemoto H., Yoshida M., et al. Alternative splicing produces a constitutively active form of human SREBP-1. Biochem. Biophys. Res. Commun. 2008, 368:820-826.
14. Harries L.W., Brown J.E., Gloyn A.L., HNF1A Species-specific differences in the expression of the HNF1B and HNF4A genes. PLoS One 2009, 4:e7855.
15. Kaestner K.H., Hiemisch H., Luckow B., et al. The HNF-3 gene family of transcription factors in mice: gene structure, cDNA sequence, and mRNA distribution. Genomics 1994, 20:377-385.
16. Schrem H., Klempnauer J., Borlak J. Liver-enriched transcription factors in liver function and development. Part II: the C/EBPs and D site-binding protein in cell cycle control, carcinogenesis, circadian gene regulation, liver regeneration, apoptosis, and liver-specific gene regulation. Pharmacol. Rev. 2004, 56:291-330.
17. Horton J.D., Goldstein J.L., Brown M.S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J. Clin. Invest. 2002, 109:1125-1131.
18. Espenshade P.J. SREBPs: sterol-regulated transcription factors. J. Cell Sci. 2006, 119:973-976.
19. Cha J.Y., Kim H., Kim K.S., et al. Identification of transacting factors responsible for the tissue-specific expression of human glucose transporter type 2 isoform gene. Cooperative role of hepatocyte nuclear factors 1alpha and 3beta. J. Biol. Chem. 2000, 275:18358-18365.
20. Fukui K., Wada T., Kagawa S., et al. Impact of the liver-specific expression of SHIP2 (SH2-containing inositol 5'-phosphatase 2) on insulin signaling and glucose metabolism in mice. Diabetes 2005, 54:1958-1967.
21. Rinella M.E., Elias M.S., Smolak R.R., et al. Mechanisms of hepatic steatosis in mice fed a lipogenic methionine choline-deficient diet. J. Lipid Res. 2008, 49:1068-1076.
22. Yahagi N., Shimano H., Hasty A.H., et al. Absence of sterol regulatory element-binding protein-1 (SREBP-1) ameliorates fatty livers but not obesity or insulin resistance in Lep(ob)/Lep(ob) mice. J. Biol. Chem. 2002, 277:19353-19357.
23. Wendel A.A., Li L.O., Li Y., et al. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity. Diabetes 2010, 59:1321-1329.